5-HT2C receptor — Drug Target

All drugs that target 5-HT2C receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

5-HT2C receptor agonist

Marketed (1)

• Lorcaserin HCl · Beth Israel Deaconess Medical Center · 5-HT2C receptor agonist · Obesity/Weight Management
  Lorcaserin is a selective serotonin 5-HT2C receptor agonist that promotes weight loss by increasing satiety and reducing appetite.

Phase 3 pipeline (2)

• OPC-1085EL · Otsuka Beijing Research Institute · 5-HT2C receptor agonist · Obesity/Metabolic Disease
  OPC-1085EL is a selective serotonin 5-HT2C receptor agonist that promotes weight loss by increasing satiety and reducing appetite.
• JNT-517 Tablet · Otsuka Pharmaceutical Development & Commercialization, Inc. · 5-HT2C receptor agonist · Obesity / Metabolic Disease
  JNT-517 is a selective serotonin 5-HT2C receptor agonist that promotes weight loss by increasing satiety and reducing appetite.